Generation of Human Nasal Epithelial Cell Spheroids for Individualized Cystic Fibrosis Transmembrane Conductance Regulator Study
April 11th, 2018
10K views
Here we describe a method to generate three-dimensional spheroid cultures of human nasal epithelial cells. Spheroids are then stimulated to drive Cystic Fibrosis Transmembrane Conductance Regulator (CFTR)-dependent ion and fluid secretion, quantifying the change in the spheroid luminal size as a proxy for CFTR function.
Overview
This article presents a method for generating three-dimensional spheroid cultures of human nasal epithelial cells, which can be used to study CFTR function. The spheroids are stimulated to assess CFTR-dependent ion and fluid secretion, with changes in luminal size serving as a functional proxy.
Key Study Components
Area of Science
- Neuroscience
- Cell Biology
- Cystic Fibrosis Research
Background
- Human nasal epithelial cells are crucial for studying cystic fibrosis.
- Spheroid cultures provide a relevant ex vivo model for functional assays.
- CFTR is essential for ion and fluid transport in epithelial cells.
- Assessing drug responses in these models can inform treatment strategies.
Purpose of Study
- To develop a reliable method for creating nasal epithelial cell spheroids.
- To evaluate CFTR function through luminal size changes in response to stimulation.
- To facilitate extensive testing of CFTR-modulating drugs.
Methods Used
- Isolation and expansion of human nasal epithelial cells.
- Creation of spheroids using a basement membrane matrix.
- Stimulation of spheroids to measure CFTR activity.
- Microscopic evaluation of spheroid morphology and function.
Main Results
- Spheroids formed within 3-5 days and matured in approximately 10 days.
- Functional assays indicated varying responses based on CFTR status.
- Successful cultures yielded 50-100 spheroids per matrix drop.
- Clear lumens were observed in wild-type CFTR spheroids.
Conclusions
- The method allows for rapid generation of nasal epithelial spheroids.
- These spheroids can serve as a valuable tool for CFTR research.
- Further studies can enhance understanding of cystic fibrosis treatments.
Frequently Asked Questions
What is the significance of CFTR in nasal epithelial cells?
CFTR is critical for ion and fluid transport, and its dysfunction leads to cystic fibrosis.
How are spheroids generated from nasal epithelial cells?
Spheroids are created by culturing cells in a basement membrane matrix, allowing them to aggregate and form three-dimensional structures.
What are the advantages of using spheroid cultures?
Spheroid cultures provide a more physiologically relevant model for studying cellular functions and drug responses compared to traditional two-dimensional cultures.
How can this method assist in drug testing?
The spheroids can be used to assess individual responses to CFTR-modulating drugs, aiding in personalized medicine approaches for cystic fibrosis.
What are the expected outcomes when stimulating spheroids?
Spheroids from subjects with functional CFTR should swell upon stimulation, while those with dysfunctional CFTR will show reduced swelling or shrinkage.
Executive Industry Relevance
Patient-derived models that capture individual CFTR function enable early de-risking of modulator therapies by predicting clinical response before patient exposure. This approach addresses limitations in genotype-directed therapy by providing a functional readout for rare or understudied mutations not represented in clinical trials. The model supports go/no-go decisions in CFTR modulator development by linking ex vivo spheroid response to individualized treatment optimization.
Strategic Applications in Biopharma R&D
Early Discovery & Target Validation
- Scientific Value: Enables interrogation of CFTR function and modulation in a genetically matched, patient-specific system.
- Operational Value: Uses minimally invasive nasal epithelial cells to generate reproducible spheroids for functional testing.
- Scientific Value: Supports mechanistic de-risking by quantifying CFTR activity as a proxy for ion and fluid transport.
Screening & Assay Development
- Scientific Value: Provides a quantitative readout of CFTR function via spheroid swelling in response to cAMP agonists.
- Operational Value: Allows rapid maturation within 10 days, reducing contamination risk compared to air-liquid interface cultures.
- Operational Value: Enables extensive testing from small tissue samples due to high spheroid yield per matrix drop.
Translational & Preclinical Research
- Scientific Value: Reflects disease-relevant epithelium with direct linkage to CF morbidity and mortality.
- Operational Value: Serves as a preclinical predictor of patient response to CFTR modulators when tied to in vivo outcomes.
- Scientific Value: Facilitates assessment of modulator efficacy in homozygous F508del and other CFTR genotypes.
Pipeline & Workflow Integration
The method integrates into the discovery continuum by enabling functional validation of CFTR targets prior to lead optimization and preclinical candidate selection.
- Discovery Biology: Supports hypothesis testing of CFTR modulation through measurable luminal size changes.
- Screening: Delivers reproducible, quantitative functional outputs for compound evaluation in individualized contexts.
- Analytics: Generates swelling-based readouts that allow comparison of CFTR activity across genotypes and treatment conditions.
- Translational Research: Connects ex vivo CFTR function to potential in vivo drug response through ongoing correlation studies.
- Enterprise Reuse: Establishes a scalable, standardized platform for longitudinal CFTR modulator assessment across patient cohorts.
Operational & Enterprise Impact
- Scientific Value: Predictive confidence in CFTR modulation through direct functional measurement of channel activity.
- Operational Value: Standardized spheroid formation and stimulation protocol ensures reproducibility across users and sites.
- Strategic Value: Informs capital-efficient modulator selection by identifying non-responders early in development.
- Portfolio Impact: Enables risk-adjusted advancement of CFTR modulators based on individualized preclinical efficacy.
Implementation Considerations
- Requires expertise in primary human tissue handling and conditional reprogramming of nasal epithelial cells.
- Dependent on access to basement membrane matrix and controlled incubation equipment for spheroid formation.
- Necessitates standardized medium exchange and stimulation protocols to ensure consistent CFTR functional readouts.
- Involves adaptation considerations when applying the model to different CFTR genotypes or modulator combinations.
- Limited by low throughput, which is balanced by the ease of nasal tissue acquisition and minimal invasiveness.
Biopharma FAQs
Why does quantifying spheroid swelling matter for CFTR target validation?
Spheroid swelling serves as a functional proxy for CFTR-mediated ion and fluid secretion, enabling direct assessment of channel activity. This readout allows researchers to distinguish between functional and dysfunctional CFTR genotypes based on luminal size changes upon stimulation. It provides a quantitative basis for evaluating modulator efficacy in a patient-specific context.
How does isolating the independent variable (genotype) improve discovery pipeline decisions?
By using patient-derived HNEs with known CFTR genotypes, the model isolates genetic background as the key variable influencing CFTR function. This enables clear attribution of functional differences to specific mutations rather than cultural or environmental noise. It supports reliable genotype-phenotype mapping essential for target validation in CFTR modulator development.
What do quantitative dependent variable measurements (swelling kinetics) enable in preclinical screening?
Time-resolved swelling measurements provide objective, quantifiable data on CFTR activation and inhibition under controlled conditions. These measurements allow comparison of modulator effects across genotypes and help identify partial responders or non-responders. The data supports go/no-go decisions by establishing functional thresholds for therapeutic benefit.
Why do replication requirements matter for cross-functional collaboration in CFTR assay development?
Consistent spheroid formation and swelling responses across replicates ensure assay reliability for multi-site or multi-user testing environments. Standardized protocols minimize variability, enabling comparable results between discovery, translational, and clinical teams. This reproducibility is essential for building confidence in preclinical predictions of patient response.
What statistical analysis capabilities are required before implementing spheroid-based CFTR assays?
The ability to compare swelling responses between wild-type, mutant, and modulator-treated conditions using appropriate statistical tests is essential. Analysis must account for biological variability between patient samples while detecting significant differences in CFTR function. This ensures that observed effects are robust and not due to random variation, supporting data-driven advancement decisions.
